Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer

Breast J. 2018 Jul;24(4):695-697. doi: 10.1111/tbj.12990. Epub 2017 Dec 29.

Authors

Lore Decoster¹, Christel Fontaine¹, Leen Vanacker¹, Denis Schallier¹, Jacques De Grève¹

Affiliation

¹ Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Oncologisch Centrum, Brussel, Belgium.

PMID: 29286203
DOI: 10.1111/tbj.12990

No abstract available

MeSH terms

Aged
Aged, 80 and over
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Breast Neoplasms / drug therapy*
Chemotherapy, Adjuvant
Cyclophosphamide / administration & dosage
Cyclophosphamide / adverse effects*
Docetaxel / administration & dosage
Docetaxel / adverse effects*
Female
Humans
Retrospective Studies

Substances

Antineoplastic Agents
Docetaxel
Cyclophosphamide